301.37
0.00
(0.00%)
At close: January 10 at 3:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CHF | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 15 | 16 |
| Avg. Estimate | 14.91B | 15.4B | 60.76B | 64.13B |
| Low Estimate | 14.82B | 15.4B | 60.02B | 62.1B |
| High Estimate | 15.07B | 15.41B | 62.19B | 66.23B |
| Year Ago Sales | 14.27B | 14.66B | 58.72B | 60.76B |
| Sales Growth (year/est) | 4.48% | 5.06% | 3.48% | 5.55% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RHHBF | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Related Tickers
SNYNF Sanofi
99.28
0.00%
NOTA.SG Novartis AG
96.80
-0.21%
AZNCF AstraZeneca PLC
135.50
0.00%
NVSEF Novartis AG
99.24
0.00%
600666.SS Aurora Optoelectronics Co.,Ltd.
2.1900
-5.19%
ZEG.F AstraZeneca PLC
131.35
-0.61%
SNW.HM Sanofi SA
95.59
-0.93%
DSKYF Daiichi Sankyo Company, Limited
25.50
0.00%
PFE.DU Pfizer Inc
26.32
+1.08%
AMG.DE Amgen Inc.
256.10
-0.02%